期刊文献+

埃索美拉唑与奥美拉唑治疗十二指肠溃疡疗效比较 被引量:1

Comparative study of Esomeprazole versus Omemeprazole in patients with duodenal ulcer
下载PDF
导出
摘要 目的评估埃索美拉唑治疗十二指肠溃疡(duodenal ulcer,DU)的临床疗效和安全性。方法 70例DU患者,分别用埃索美拉唑片剂40 mg,qd和奥美拉唑胶囊40 mg,qd进行治疗,胃镜观察溃疡愈合程度。结果4周后埃索美拉唑组和奥美拉唑组溃疡愈合率分别为91.4%和88.6%,总有效率分别为97.1%和94.2%。但埃索美拉唑比奥美拉唑缓解DU疼痛更为快速,埃索美拉唑组1 d内的疼痛消失率为42.9%,而奥美拉唑组为14.3%。结论埃索美拉唑治疗DU具有较好的疗效,且无明显不良反应,值得临床推广。 Objective To evaluate the effect and safety of esomeprazole in patients with duodenal ulcer. Methods70 patients with duodenal ulcerwere randomly assigned to receive one of the two regimens.they were esomeprazole(S-OPZ)40mg oral qd and omemeprazole(OPZ)40mg qd.Endoscopies and routine lboratory tests were performed before the rial and within 3 days after the rial to assess therapeutic efficacy. Results After 4weeks of treatment,the ulcer-healing rate achived91.4% of S-OPZ patients and 88.6% of OPZ patients,the general effective rate achived97.1% and 94.2%recpectively in both groups.The trial results showed that the pain rilief rate within first 0ne day after the treatment in S-OPZ group and OPZ group was 42.9% and 14.3% respectively.It appears that S-OPZ is quicker in relieving the ulcer pain than OPZ. Conclusions The result suggests that S-OPZis a very effective and well-tolerated proton pump inhibitors and it is worthy to be recommended for administration in patients with duodenal ulcer.
作者 方玉成
机构地区 宁国市人民医院
出处 《基层医学论坛》 2016年第4期445-447,共3页 The Medical Forum
关键词 十二指肠溃疡 质子泵抑制剂 埃索美拉唑 奥美拉唑 Duodenal ulcer Proton pump inhibitors Esomeprazole Omemeprazole
  • 相关文献

参考文献5

二级参考文献58

  • 1楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 2芮庄生,甘结友.质子泵抑制剂的药理及临床应用[J].临床和实验医学杂志,2006,5(3):270-271. 被引量:49
  • 3姚方.埃索美拉唑在消化性溃疡病治疗中的地位[J].中华消化杂志,2006,26(5):355-357. 被引量:30
  • 4Junghard O,hassan Alin M,Hasselgren G.The effete of auc and cmax of esomep zole on acid secretion and intra 2 gastric pH[J].Gastroenterology,2000,118:17.
  • 5陈灏珠.实用内科学[M].11 版.北京:人民卫生出版社,1998:1562-1565.
  • 6中华医学会消化内镜学会.反流性食管炎诊断与治疗方案(试行)[J].中华消化内科杂志,1999,16(4):326-326.
  • 7Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(7):1091-1118.
  • 8Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(10):1503-1538.
  • 9Andersson T,Bredberg E,Sunzel M,et al.Pharmacokinetics and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole and its 2 optical isomers,S-omeprazole / esomeprazole and R-omeprazole[J].Gastroenterology,2000,118∶A1210.
  • 10Abelo A,Andersson TB,Antonsson M,et al.Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes[J].Drug Metab Dispos,2000,28(8):966-972.

共引文献114

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部